Navigation Links
Canadian Medical Device Set to Speed Treatment and Cut Health Care Costs for Common Cause of Vertigo
Date:4/21/2009

A new Canadian medical device, the DizzyFIX, is now available worldwide for self-directed home treatment of the most common cause of spinning vertigo, also called BPPV (Benign Paroxysmal Positional Vertigo).

Edmonton, Canada (PRWEB) April 14, 2009 -- A new Canadian medical device is now available worldwide for self-directed home treatment of BPPV (Benign Paroxysmal Positional Vertigo), the most common cause of spinning vertigo.



While causes can range from complications associated with aging to the shock of a violent collision, BPPV results from the collection of tiny particles in the balance canals of the inner ear. When these particles shift with head motion, they confuse the balance organ, leading to vertigo and the accompanying debilitating dizziness.

BPPV is treated using a specific series of head and body positions known as the Epley Maneuver, designed to guide the errant particles back to their proper place. Traditionally, vertigo treatment using Epley Maneuver required a visit to a specialist physician, which could mean months of disruptive dizziness for patients stuck on waiting lists. Even after a successful clinical treatment, BPPV is often recurrent and it has been estimated that, unfortunately, only about 8% of persons suffering from BPPV receive appropriate treatment.

The DizzyFIX is an award winning, inexpensive, visual feedback device that allows people suffering from BPPV to retake control of their lives through a simple, self-directed vertigo treatment. It guides patients through the Epley Maneuver, which allows those with recurrent vertigo to treat their BPPV immediately in the comfort of their own home. Clinical trials show an 88% success rate using the device, which improves patient satisfaction and spares the health care system the cost of repeated specialist visits.

Dr. John W McDonald, Past President of the Royal College of Physicians and Surgeons, BPPV sufferer, and professor at the University of Western Ontario, where a series of clinical trials were conducted, said, "I found the device and the instructional materials easy to use. It took only one use to correct the problem. I am very grateful to you."

Featured this week on Global TV Edmonton and in the latest issue of the Alberta Heritage Foundation for Medical Research (AHFMR) News, the DizzyFIX is a patented device, developed in Canada by experts at Clearwater Clinical. The DizzyFIX has been cleared as an effective vertigo treatment by US FDA, Canada Health, and other authorities following university clinical trials. The DizzyFIX is available in 62 countries including in most Canadian pharmacies or online.

Click to view media coverage of this unique, drug-free BPPV treatment.

About Clearwater Clinical Limited
Clearwater Clinical Limited is a medical technologies company dedicated to the design, development and manufacturing of innovative medical-grade devices and surgical equipment intended for use in both the operating room and office practice. The company is based in Calgary with offices in Canada (Calgary, Edmonton, Vancouver), the United States (Cincinnati, Baltimore), and China (Hong Kong).

For more information, please contact:
Matthew Bromwich, MD, FRCS(c)
Clearwater Clinical Limited
Ph: 1-877-349-9934
www.dizzyfix.com

###

Read the full story at http://www.prweb.com/releases/vertigo/treatment/prweb2308834.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Ibuprofen can slow lung disease in children with cystic fibrosis, Canadian study shows
3. New Canadian study finds drug coated heart stents to be safe:
4. Canadians welcome HPV vaccine -- but not at any price
5. Mayo Clinic Calls for Thorough Review of Canadian Pacifics Acquisition of the Dakota, Minnesota & Eastern Railroad
6. Canadian Pacific and Mayo Clinic Build Understanding and Commit to Ongoing Dialogue
7. Map the Canadian Healthcare IT Market with the New HIMSS Analytics Canadian Database(SM)
8. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
9. Mayo Clinic Seeks Mitigation for Rochester as Condition of Canadian Pacific - DM&E Railroad Merger
10. Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study
11. Leading Travel Insurance Website Now Offers Mexican Auto Insurance to US and Canadian Travelers Going into Mexico
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Canadian Medical Device Set to Speed Treatment and Cut Health Care Costs for Common Cause of Vertigo
(Date:5/3/2016)... ... May 03, 2016 , ... ... Carnival Vista – the line’s largest cruise ship ever. To help guests ... an infographic spotlighting the Carnival Vista ’s most exciting features and ...
(Date:5/2/2016)... ... ... It has just been announced Jack Uldrich, renowned futurist and ... of May. , Uldrich is the author of 11 books and a regular guest ... the Science Channel’s FutureScape and Discovery Channel’s Inside Out. , Known the world over ...
(Date:5/2/2016)... Dallas, Texas (PRWEB) , ... May 02, 2016 ... ... Volume 3, Issue 1 of Patient Experience Journal (PXJ), an international, open ... patient experience. With almost half the issue representing international (non-US) based authors, the ...
(Date:5/2/2016)... ... 02, 2016 , ... Beanfields, PBC, makers of Beanfields Bean ... students at University of Colorado in Boulder to create new advertising campaigns. , ... the School of Journalism, who selected Beanfields as the brand on which to ...
(Date:5/2/2016)... ... May 02, 2016 , ... Amica Life Insurance ... understand life insurance throughout various life stages. , The site launched on April ... calculator and content specific to the times when life insurance matters most. , ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 2016 New market research ... a report that provides an overview of the ... by identifying new targets and MOAs to produce ... discussed in this H1 2016 Osteoarthritis Pipeline report ... Inc., Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, ...
(Date:4/27/2016)... , Schweiz, April 27, 2016 /PRNewswire/ ... des Sachs CEO Forums in Zürich gab ... ihres führenden Wirkstoffkandidaten STR001 zur Erhaltung des ... eingesetzt wurde, bekannt. Für die umfassende Phase-II-Doppelblindstudie ... und Frankreich angeworben. STR001 wird während der ...
(Date:4/27/2016)... 27, 2016   ... in Recurring Consumable Sales  Clinical sales grow ... Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the ... for the first quarter ended March 31, 2016 and ... of its commercial strategy. First Quarter 2016 ...
Breaking Medicine Technology: